StradBio

stradbio.com
401 Terry Ave. N
Seattle, WA 98109-5263

Company Info

Year Established
2023

Contacts

Jonathan Drachman, MD
Co-Founder & CEO

Company Description

StradBio is creating the next generation of immunotherapies for cancer and inflammatory diseases. Through precision-tuned cytokine mimetics, targeting, and logic gates, they are building drugs that can deliver potent activation of immune cells where they are needed most, minimizing side effects.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.